M L R Monteiro1, C L Afonso1. 1. Division of Ophthalmology, University of São Paulo Medical School, São Paulo, Brazil.
Abstract
PURPOSE: To evaluate the ability of frequency domain-optical coherence tomography (FD-OCT)-measured macular thickness parameters to differentiate between eyes with resolved chronic papilledema and healthy eyes and to evaluate the correlation between FD-OCT measures and visual field (VF) loss on standard automated perimetry (SAP). METHODS: Fifty-two eyes from 29 patients suffering from pseudotumor cerebri syndrome (PTC) and 62 eyes from 31 normal controls underwent FD-OCT scanning and ophthalmic evaluation including VF with SAP. All patients had previously been submitted to treatment of PTC and had clinically resolved papilledema and stable VF for at least 6 months before the study. Macular and peripapillary retinal nerve fiber layer (RNFL) thickness measurements were determined for both groups. Comparisons were made using Generalized Estimated Equations. Correlations between FD-OCT and VF measurements were verified. RESULTS: In eyes with resolved papilledema, the macular thickness parameters corresponding to the inner and outer superior, temporal, inferior and nasal segments, average macular thickness and most RNFL thickness measurements were significantly reduced when compared with controls. The discrimination ability was similar for macular thickness measurements and RNFL thickness measurements. Both sets of OCT measurements correlated well with VF sensitivity loss. CONCLUSIONS: Eyes with resolved chronic papilledema show a significant reduction in macular thickness, which is well correlated with the severity of VF loss. Macular thickness measurements can potentially be used to estimate and monitor the amount of ganglion cell loss in eyes with papilledema from patients with PTC.
PURPOSE: To evaluate the ability of frequency domain-optical coherence tomography (FD-OCT)-measured macular thickness parameters to differentiate between eyes with resolved chronic papilledema and healthy eyes and to evaluate the correlation between FD-OCT measures and visual field (VF) loss on standard automated perimetry (SAP). METHODS: Fifty-two eyes from 29 patients suffering from pseudotumor cerebri syndrome (PTC) and 62 eyes from 31 normal controls underwent FD-OCT scanning and ophthalmic evaluation including VF with SAP. All patients had previously been submitted to treatment of PTC and had clinically resolved papilledema and stable VF for at least 6 months before the study. Macular and peripapillary retinal nerve fiber layer (RNFL) thickness measurements were determined for both groups. Comparisons were made using Generalized Estimated Equations. Correlations between FD-OCT and VF measurements were verified. RESULTS: In eyes with resolved papilledema, the macular thickness parameters corresponding to the inner and outer superior, temporal, inferior and nasal segments, average macular thickness and most RNFL thickness measurements were significantly reduced when compared with controls. The discrimination ability was similar for macular thickness measurements and RNFL thickness measurements. Both sets of OCT measurements correlated well with VF sensitivity loss. CONCLUSIONS: Eyes with resolved chronic papilledema show a significant reduction in macular thickness, which is well correlated with the severity of VF loss. Macular thickness measurements can potentially be used to estimate and monitor the amount of ganglion cell loss in eyes with papilledema from patients with PTC.
Authors: Kyung Rim Sung; Gadi Wollstein; Na Rae Kim; Jung Hwa Na; Jessica E Nevins; Chan Yun Kim; Joel S Schuman Journal: Br J Ophthalmol Date: 2012-09-27 Impact factor: 4.638
Authors: Shiv Saidha; Stephanie B Syc; Mohamed A Ibrahim; Christopher Eckstein; Christina V Warner; Sheena K Farrell; Jonathan D Oakley; Mary K Durbin; Scott A Meyer; Laura J Balcer; Elliot M Frohman; Jason M Rosenzweig; Scott D Newsome; John N Ratchford; Quan D Nguyen; Peter A Calabresi Journal: Brain Date: 2011-01-20 Impact factor: 13.501
Authors: Mário L R Monteiro; Danilo B Fernandes; Samira L Apóstolos-Pereira; Dagoberto Callegaro Journal: Invest Ophthalmol Vis Sci Date: 2012-06-26 Impact factor: 4.799
Authors: Falko Kaufhold; Ella Maria Kadas; Christoph Schmidt; Hagen Kunte; Jan Hoffmann; Hanna Zimmermann; Timm Oberwahrenbrock; Lutz Harms; Konrad Polthier; Alexander U Brandt; Friedemann Paul Journal: PLoS One Date: 2012-05-15 Impact factor: 3.240
Authors: Mark Thaller; Victoria Homer; Yousef Hyder; Andreas Yiangou; Anthony Liczkowski; Anthony W Fong; Jasvir Virdee; Rachel Piccus; Marianne Roque; Susan P Mollan; Alexandra J Sinclair Journal: J Neurol Date: 2022-10-15 Impact factor: 6.682
Authors: Vivek Vijay; Susan P Mollan; James L Mitchell; Edward Bilton; Zerin Alimajstorovic; Keira A Markey; Anthony Fong; Jessica K Walker; Hannah S Lyons; Andreas Yiangou; Georgios Tsermoulas; Kristian Brock; Alexandra J Sinclair Journal: JAMA Ophthalmol Date: 2020-12-01 Impact factor: 7.389
Authors: Guofu Shen; Schuyler Link; Sandeep Kumar; Derek M Nusbaum; Dennis Y Tse; Yingbin Fu; Samuel M Wu; Benjamin J Frankfort Journal: Sci Rep Date: 2018-02-12 Impact factor: 4.379